PSMB8 and colitis: Previous studies have shown that the absence or the inhibition of the immunosubunit β5i/LMP7 protects mice against development of DSS-induced colitis, which was attributed to diminished transcription of (pro)inflammatory cytokines or to diminished Th1 and Th17 and enhanced Treg cell differentiation [15], [17].